শুধুমাত্র তথ্যমূলক — চিকিৎসা পরামর্শ নয়। সর্বদা লাইসেন্সপ্রাপ্ত স্বাস্থ্যসেবা প্রদানকারীর পরামর্শ নিন।

MedBD
EN
Community data Updated 2 মাস আগে

Glibenclamide

Sulfonylureas Prescription
Check interactions
🌐 View in English

ইঙ্গিত

Type 2 Diabetes Mellitus Diabetes Mellitus

Suganil is used alongside a healthy diet and regular exercise to help adults with type 2 diabetes keep their blood sugar under control.

⚠️ কোনো ওষুধ গ্রহণের আগে সর্বদা নিবন্ধিত চিকিৎসকের পরামর্শ নিন।

ফার্মাকোলজি

Glibenclamide appears to lower blood glucose in the short term by stimulating the pancreas to release insulin, an effect that depends on the beta cells in the pancreatic islets still functioning. How it lowers blood glucose with long-term use is not clearly understood. In Type 2 diabetes patients on chronic therapy, the blood-glucose-lowering effect continues even as the drug's ability to trigger insulin secretion gradually declines. Besides lowering blood glucose, Glibenclamide also produces a mild diuretic effect by increasing the kidneys' free water clearance.

Pregnancy & Breastfeeding

Pregnancy Category C. No specific data exist on Glibenclamide use during human pregnancy, but the medicine has been used widely for many years without any apparent harm being reported. Studies in animals have not shown any risk. Whether Glibenclamide passes into human breast milk is not yet known. Other sulphonylureas, however, do pass into breast milk, and there is no reason to think Glibenclamide behaves any differently in this regard.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

ডোজ নির্দেশিকা

⚠️ শুধুমাত্র সরকারি উৎস থেকে নির্দেশিকা পরিসীমা। ব্যক্তিগতকৃত ডোজের জন্য আপনার ডাক্তারের পরামর্শ নিন।

Adults: There is no single fixed dosage schedule for treating diabetes mellitus with Glibenclamide or with any other hypoglycemic medicine. As initial therapy, the usual starting dose is 2.5 to 5 mg daily, taken with breakfast or the first main meal of the day. Those patients who may be more sensitive to hypoglycemic drugs should begin at a lower dose of 1.25 mg daily. The usual maintenance dose falls in the range of 1.25 to 20 mg daily, and this may be taken as a single dose or split into divided doses. Any increase in dosage should be made in steps of no more than 2.5 mg, spaced at least a week apart, guided by the patient's blood glucose response. Daily doses above 20 mg are not recommended.

পার্শ্বপ্রতিক্রিয়া ও পারস্পরিক ক্রিয়া

পার্শ্বপ্রতিক্রিয়া

No side-effect data recorded yet.